CAS 1106685-58-8

Formula: C28H30N2O10

InChI: InChI=1S/C28H30N2O10/c1-15-14-16(2)30-27(29-15)39-23(25(36)40-26-21(33)19(31)20(32)22(38-26)24(34)35)28(37-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19-23,26,31-33H,1-3H3,(H,34,35)/t19-,20-,21+,22-,23+,26-/m0/s1

InChI key: QBHJFBFSJYTXDX-MVTLKLODSA-N

SMILES: CC1=CC(=NC(=N1)O[C@H](C(=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)C(C3=CC=CC=C3)(C4=CC=CC=C4)OC)C

Ambrisentan Acyl Beta-D-Glucuronide

Controlled Product

CAS: 1106685-58-8

Applications A glucuronide metabolite of Ambrisentan (A575860).

Formula: C₂₈H₃₀N₂O₁₀

Color and Shape: Neat

Molecular weight: 554.55

Ref: TR-A575870

Ambrisentan acyl-beta-D-glucuronide-[d10]

CAS: 1106685-58-8

Formula: C₂₈H₃₀N₂O₁₀

Molecular weight: 554.5

Ref: BE-MD-7471

Ambrisentan Acyl β-D-Glucuronide

CAS: 1106685-58-8

Formula: C₂₈H₃₀N₂O₁₀

Molecular weight: 554.55

Ref: ST-EA-CP-A15014

Ambrisentan acyl β-D-glucuronide

CAS: 1106685-58-8

Ambrisentan is a drug product that is used in the treatment of pulmonary hypertension. Ambrisentan is metabolized to ambrisentan acyl β-D-glucuronide, a natural metabolite that has been synthesized as an analytical standard. It also shows antihypertensive activity and is currently under development for use in the treatment of heart failure.

Formula: C₂₈H₃₀N₂O₁₀

Purity: Min. 95%

Molecular weight: 554.5 g/mol

Ref: 3D-GUB68558